INDEMNIFICATION AGREEMENTIndemnification Agreement • June 10th, 2021 • Dermata Therapeutics, Inc. • Pharmaceutical preparations • Delaware
This Indemnification Agreement (“Agreement”) is made as of _________ __, ___ by and between Dermata Therapeutics, Inc., a Delaware corporation (the “Company”), and ______________ (“Indemnitee”).
INCENTIVE STOCK OPTION GRANT AGREEMENT DERMATA THERAPEUTICS, INC.Incentive Stock Option Grant Agreement • June 10th, 2021 • Dermata Therapeutics, Inc. • Pharmaceutical preparations • Delaware
This Stock Option Grant Agreement (the “Grant Agreement”) is made and entered into effective on the Date of Grant set forth in Exhibit A (the “Date of Grant”) by and between Dermata Therapeutics, Inc., a Delaware corporation (the “Company”), and the individual named in Exhibit A hereto (the “Optionee”).
NONQUALIFIED STOCK OPTION GRANT AGREEMENT DERMATA THERAPEUTICS, INC.Nonqualified Stock Option Grant Agreement • June 10th, 2021 • Dermata Therapeutics, Inc. • Pharmaceutical preparations • Delaware
This Stock Option Grant Agreement (the “Grant Agreement”) is made and entered into effective on the Date of Grant set forth in Exhibit A (the “Date of Grant”) by and between Dermata Therapeutics, Inc., a Delaware corporation (the “Company”), and the individual named in Exhibit A hereto (the “Optionee”).
EMPLOYMENT AGREEMENTEmployment Agreement • June 10th, 2021 • Dermata Therapeutics, Inc. • Pharmaceutical preparations • California
This EMPLOYMENT AGREEMENT (this “Agreement”), effective _____, 2021 (the “Effective Date”), is by and between DERMATA THERAPEUTICS, LLC, a Delaware corporation (the “Company”) and Gerry Proehl (the “Executive”).
DERMATA THERAPEUTICS, INC. STOCKHOLDERS’ AGREEMENTStockholders’ Agreement • June 10th, 2021 • Dermata Therapeutics, Inc. • Pharmaceutical preparations • California
THIS STOCKHOLDERS’ AGREEMENT (this “Agreement”) is made as of the 24th day of March, 2021 (the “Effective Date”) by and among Dermata Therapeutics, Inc. a Delaware corporation (the “Company”), and the parties listed on Schedule A hereto (together with any subsequent stockholders, or any transferees, who become parties hereto as “Stockholders” pursuant to the terms hereof, “Stockholder” and, collectively, the “Stockholders”).
WARRANT TO PURCHASE COMMON STOCK DERMATA THERAPEUTICS, INC.Grant Agreement • June 10th, 2021 • Dermata Therapeutics, Inc. • Pharmaceutical preparations • Delaware
This Warrant (the “Grant Agreement”) is made and entered into effective on the Date of Grant set forth in Exhibit A (the “Date of Grant”) by and between Dermata Therapeutics, Inc., a Delaware corporation (the “Company”), and the individual named in Exhibit A hereto (the “Holder”).
AMENDMENT NO. 1 TO STOCKHOLDERS’ AGREEMENTStockholders’ Agreement • June 10th, 2021 • Dermata Therapeutics, Inc. • Pharmaceutical preparations • Delaware
THIS AMENDMENT NO. 1 (this “Amendment”) to the Stockholders’ Agreement dated as of March 24, 2021 (the “Agreement”), by and among Dermata Therapeutics, Inc., a Delaware corporation (the “Company”), and each of the stockholders listed on Schedule A thereto (collectively, the “Stockholders”), is made as of May 27, 2021 by and among the Company and the entities listed on the signature pages hereto. Each capitalized term used herein and not otherwise defined shall have the meaning ascribed to that term in the Agreement.
